Host: |
Rabbit |
Applications: |
WB/IHC |
Reactivity: |
Human/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit monoclonal antibody anti-HOXA9 (173-272) is suitable for use in Western Blot and Immunohistochemistry research applications. |
Clonality: |
Monoclonal |
Clone ID: |
S9MR |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:1000IHC-P 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
HOXA9 |
Gene ID: |
3205 |
Uniprot ID: |
HXA9_HUMAN |
Immunogen Region: |
173-272 |
Immunogen: |
A synthetic peptide corresponding to a sequence within amino acids 173-272 of human HOXA9 (P31269). |
Immunogen Sequence: |
GAFSENNAENESGGDKPPID PNNPAANWLHARSTRKKRCP YTKHQTLELEKEFLFNMYLT RDRRYEVARLLNLTERQVKI WFQNRRMKMKKINKDRAKDE |
Post Translational Modifications | Methylated on Arg-140 by PRMT5.methylation is critical for E-selectin induction. |
Function | Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Required for induction of SELE/E-selectin and VCAM1 on the endothelial cells surface at sites of inflammation. Positively regulates EIF4E-mediated mRNA nuclear export and also increases the translation efficiency of ODC mRNA in the cytoplasm by competing with factors which repress EIF4E activity such as PRH. |
Protein Name | Homeobox Protein Hox-A9Homeobox Protein Hox-1g |
Cellular Localisation | NucleusCytoplasm |
Alternative Antibody Names | Anti-Homeobox Protein Hox-A9 antibodyAnti-Homeobox Protein Hox-1g antibodyAnti-HOXA9 antibodyAnti-HOX1G antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance